Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01821898 · ClinicalTrials.gov registry record · Phase 2
Eosinophilic Esophagitis Clinical Therapy Comparison Trial
A Phase 2 study, sponsored by Baylor College of Medicine.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT01821898 is a Phase 2 study that was terminated before completion, run by Baylor College of Medicine. The registered enrollment target is 3 participants.
The verdict
NCT01821898, a Phase 2 study, was terminated before completion, sponsored by Baylor College of Medicine.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
Eosinophilic Esophagitis (EoE) is a disorder in which a type of white blood cell (eosinophil) involved in allergic reactions, enter and cover the walls of the esophagus (food pipe). As a result, the esophagus becomes swollen and blocked making it difficult to swallow, and this leads to heartburn. In severe cases it can lead to food getting stuck in the esophagus and poor growth or weight loss in children The main purpose of this research study is to compare the effectiveness of two different types of treatment for EoE: 1. Oral viscous budesonide- which is a steroid medication that has been used to treat asthma. Recently, it has been used as a therapy to treat the eosinophilic inflammation in EoE, and 2. Specific food elimination. The study will also be looking to see if a blood test is useful in following the progression of EoE. Currently the only way to follow EoE is by repeating endoscopy, which is a more "invasive test."
Interventions
- DRUG Oral Budesonide
- OTHER Elimination diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2013-07-09 |
| Est. Completion | 2018-09-24 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01821898
The ClinicalTrials.gov registry entry for NCT01821898 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Oral Budesonide is the first listed.
NCT01821898 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01821898 about?
NCT01821898 is a clinical study titled "Eosinophilic Esophagitis Clinical Therapy Comparison Trial". Eosinophilic Esophagitis (EoE) is a disorder in which a type of white blood cell (eosinophil) involved in allergic reactions, enter and cover the walls of the esophagus (food pipe). As a result, the esophagus becomes swollen and blocked making it difficult to swallow, and this leads to heartburn. In...
What is the current status of trial NCT01821898?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2013-07-09. Estimated completion is 2018-09-24.
What interventions are being tested in trial NCT01821898?
The interventions under investigation include: Oral Budesonide (DRUG), Elimination diet (OTHER).
Who is sponsoring clinical trial NCT01821898?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.